ARBUTUS BIOPHARMA CORP (ABUS) Stock Analyst Earnings Estimates
NASDAQ:ABUS - Nasdaq - CA03879J1003 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 10.99M 59.04% | 39.02M 255.05% | 18.141M -53.51% | 6.306M -65.24% | 5.299M -15.97% | 8.584M 61.99% | 9.485M 10.50% | 57.796M 509.34% | 178.31M 208.52% | |
| EBITDA YoY % growth | -71.77M -28.69% | -64.03M 10.78% | -76.699M -19.79% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -73.52M -27.31% | -65.46M 10.96% | -78.103M -19.31% | -82.943M -6.20% | -80.851M 2.52% | -90.633M -12.10% | -45.359M 49.95% | -56.699M -25.00% | 54.2M 195.59% | |
| Operating Margin | -668.97% | -167.76% | -430.53% | -1,315.31% | -1,525.77% | -1,055.84% | -478.22% | -98.10% | 30.40% | |
| EPS YoY % growth | -0.83 17.00% | -0.47 43.26% | -0.44 6.57% | -0.40 10.05% | -0.33 15.62% | -0.42 -25.23% | -0.18 56.00% | -0.23 -27.55% | 0.30 226.03% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.08 32.00% | -0.08 18.40% | -0.08 25.82% | -0.09 3.67% | -0.09 -9.37% |
| Revenue Q2Q % growth | 1.595M -25.64% | 1.443M -5.81% | 1.402M -18.77% | 1.387M 3.58% | 1.398M -12.35% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -19.31M 6.93% | -19.719M -1.84% | -20.131M 6.73% | -20.036M -12.47% | -20.965M -8.57% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.09 25.00% | -0.10 | 0.01 | 6.73% |
| Q2 2024 Q2Q % growth | -0.11 -10.00% | -0.10 | -0.01 | -11.41% |
| Q1 2024 Q2Q % growth | -0.10 | -0.11 | 0.01 | 10.87% |
| Q4 2023 Q2Q % growth | -0.12 14.86% | -0.12 | 0.00 | 0.30% |
| Q3 2023 Q2Q % growth | -0.12 | -0.12 | 0.00 | -3.38% |
| Q2 2023 Q2Q % growth | -0.10 | -0.11 | 0.01 | 12.62% |
| Q1 2023 Q2Q % growth | -0.10 9.09% | -0.14 | 0.04 | 27.91% |
| Q4 2022 Q2Q % growth | -0.14 6.03% | -0.14 | 0.00 | -3.12% |
| Q3 2022 Q2Q % growth | -0.12 50.00% | -0.13 | 0.01 | 8.09% |
| Q2 2022 Q2Q % growth | -0.10 56.52% | -0.13 | 0.03 | 22.19% |
| Q1 2022 Q2Q % growth | -0.11 47.62% | -0.16 | 0.05 | 32.60% |
| Q4 2021 Q2Q % growth | -0.15 34.78% | -0.19 | 0.04 | 22.60% |
| Q3 2021 Q2Q % growth | -0.24 11.11% | -0.24 | 0.00 | 1.14% |
| Q2 2021 Q2Q % growth | -0.23 8.00% | -0.23 | 0.00 | -0.97% |
| Q1 2021 Q2Q % growth | -0.21 16.00% | -0.24 | 0.03 | 11.04% |
| Q4 2020 Q2Q % growth | -0.23 50.00% | -0.23 | 0.00 | -1.83% |
| Q3 2020 Q2Q % growth | -0.27 75.45% | -0.22 | -0.05 | -22.55% |
| Q2 2020 Q2Q % growth | -0.25 45.65% | -0.24 | -0.01 | -2.12% |
| Q1 2020 Q2Q % growth | -0.25 34.21% | -0.32 | 0.07 | 21.94% |
| Q4 2019 Q2Q % growth | -0.46 | -0.37 | -0.09 | -24.58% |
| Q3 2019 Q2Q % growth | -1.10 | -0.27 | -0.83 | -306.96% |
| Q2 2019 Q2Q % growth | -0.46 | -0.38 | -0.08 | -21.07% |
| Q1 2019 Q2Q % growth | -0.38 | -0.33 | -0.05 | -15.52% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 1.339M -71.25% | 1.898M | -559K | -29.45% |
| Q2 2024 Q2Q % growth | 1.726M -62.89% | 1.79M | -64K | -3.58% |
| Q1 2024 Q2Q % growth | 1.532M -77.09% | 2.769M | -1.237M | -44.67% |
| Q4 2023 Q2Q % growth | 2.145M -65.68% | 4.889M | -2.744M | -56.13% |
| Q3 2023 Q2Q % growth | 4.658M -21.71% | 4.847M | -189K | -3.90% |
| Q2 2023 Q2Q % growth | 4.651M -67.34% | 6.31M | -1.659M | -26.29% |
| Q1 2023 Q2Q % growth | 6.687M -46.84% | 6.149M | 538K | 8.75% |
| Q4 2022 Q2Q % growth | 6.25M 94.70% | 6.299M | -49K | -0.78% |
| Q3 2022 Q2Q % growth | 5.95M 78.14% | 9.561M | -3.611M | -37.77% |
| Q2 2022 Q2Q % growth | 14.24M 511.16% | 6.903M | 7.337M | 106.29% |
| Q1 2022 Q2Q % growth | 12.58M 496.21% | 4.455M | 8.125M | 182.38% |
| Q4 2021 Q2Q % growth | 3.21M 34.31% | 2.932M | 278K | 9.48% |
| Q3 2021 Q2Q % growth | 3.34M 119.74% | 2.432M | 908K | 37.34% |
| Q2 2021 Q2Q % growth | 2.33M 54.30% | 2.165M | 165K | 7.62% |
| Q1 2021 Q2Q % growth | 2.11M 41.61% | 3.372M | -1.262M | -37.43% |
| Q4 2020 Q2Q % growth | 2.39M 47.53% | 1.997M | 393K | 19.68% |
| Q3 2020 Q2Q % growth | 1.52M -50.33% | 1.696M | -176K | -10.38% |
| Q2 2020 Q2Q % growth | 1.51M 132.31% | 1.773M | -263K | -14.83% |
| Q1 2020 Q2Q % growth | 1.49M 119.12% | 1.326M | 164K | 12.37% |
| Q4 2019 Q2Q % growth | 1.62M | 1.931M | -311K | -16.11% |
| Q3 2019 Q2Q % growth | 3.06M | 5.381M | -2.321M | -43.13% |
| Q2 2019 Q2Q % growth | 650K | 802.485K | -152.485K | -19.00% |
| Q1 2019 Q2Q % growth | 680K | 1.261M | -581K | -46.07% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 4.08% | 0% | 0.87% |
| Revenue | -1.24% | -5.9% | 0% | -2.4% |